Artigo de periodico

A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections (2021)

• Authors:
  • Wendel, Silvano
  • Wendel, Rita Fontão
  • Fachini, Roberta
  • Candelaria, Gabriela
  • Scuracchio, Patricia
  • Achkar, Ruth
  • Brito, Mayra
  • Reis, Luiz Fernando
  • Camargo, Anamaria
  • Amano, Mariane Tami
  • Machado, Rafael Rahal Guaragna
  • Araujo, Danielle Bastos
  • Soares, Camila Pereira
  • Durigon, Edison Luiz
• USP affiliated authors: DURIGON, EDISON LUIZ - ICB ; MACHADO, RAFAEL RAHAL GUARAGNA - ICB ; SOARES, CAMILA PEREIRA - ICB
• Unidade: ICB
• DOI: 10.1111/trf.16323
• Subjects: MICROBIOLOGIA; SANGUE; PLASMA; COVID-19; ESTUDOS LONGITUDINAIS; CINÉTICA QUÍMICA; ANTICORPOS; REAÇÃO EM CADEIA POR POLIMERASE; ESTUDOS DE COORTES
• Agências de fomento:
  • Financiado pela FAPESP
  • Financiado pela CAPES
• Language: Inglês
• Imprenta:
  • Publisher: Wiley-Blackwell Publishing, Inc.
  • Publisher place: Hoboken
  • Date published: 2021
• Source:
  • Título: Transfusion
  • ISSN: 1537-2995
  • Volume/Número/Paginação/Ano: 14 p., 2021

Informações sobre o DOI: 10.1111/trf.16323 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo é de acesso aberto
• URL de acesso aberto
• Cor do Acesso Aberto: green

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  WENDEL, Silvano et al. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections. Transfusion, p. 14 , 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16323. Acesso em: 27 dez. 2025.

• APA

  Wendel, S., Wendel, R. F., Fachini, R., Candelaria, G., Scuracchio, P., Achkar, R., et al. (2021). A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections. Transfusion, 14 . doi:10.1111/trf.16323

• NLM

  Wendel S, Wendel RF, Fachini R, Candelaria G, Scuracchio P, Achkar R, Brito M, Reis LF, Camargo A, Amano MT, Machado RRG, Araujo DB, Soares CP, Durigon EL. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections [Internet]. Transfusion. 2021 ;14 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1111/trf.16323

• Vancouver

  Wendel S, Wendel RF, Fachini R, Candelaria G, Scuracchio P, Achkar R, Brito M, Reis LF, Camargo A, Amano MT, Machado RRG, Araujo DB, Soares CP, Durigon EL. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections [Internet]. Transfusion. 2021 ;14 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1111/trf.16323

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections
• Anti‐A and SARS‐CoV‐2: an intriguing association
• Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be?
• Development and validation of an enzyme-linked immunoassay kit for diagnosis and surveillance of COVID-19
• Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice
• Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
• Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program
• SARS-CoV-2 rapid antigen test based on a new anti-nucleocapsid protein monoclonal antibody: development and real-time validation
• Heterogeneous development of children with congenital Zika Syndrome-associated microcephaly
• Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial